TGF-β can induce SMAD4 inactivation in cancer cells, recruit CCR1+ neutrophils through the CCL15/CCR1 axis and mediate the progression and metastases of CRC [120,121,122]. This evidence concerns the gene TGFB1 and colorectal carcinoma.